MELK and cancer: Like Lin et al., the analysis by Huang et al. included CRISPR-mediated deletion of MELK in cancer cells, as well as the discovery of a novel potent and more MELK-selective inhibitor that failed to significantly affect the growth of putatively MELK-dependent cells.